SEC Form 4 · accession 0001337798-26-000004
Kiniksa Pharmaceuticals International, plc · KNSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G Bradley Cole
Director
Period of report
Jul 29, 2026
Accepted (ET)
Jul 31, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001730430
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Jul 29, 2026 | S | 3,673 | $81.43 | D | 11,672 | D | |
| Class A Ordinary Share | Jul 29, 2026 | G | 4,500 | $0.00 | D | 7,172 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.